Glaucoma News

NEW YORK — In a presentation at OSN New York, Sarah H. Van Tassel, MD, provides insight on effectively performing goniotomy and discusses when it is most appropriate to use.

NEW YORK — In a presentation at OSN New York, Nathan Radcliffe, MD, discusses the benefits of performing selective laser trabeculoplasty on patients with open-angle glaucoma.

NEW YORK — In a presentation at OSN New York Retina, Rajendra S. Apte, MD, PhD, provides insight on managing macular and retinal diseases in patients with advanced glaucoma.

NEW YORK — In a presentation at OSN New York, Nathan Radcliffe, MD, explains why canaloplasty is an effective technique for lowering IOP and offers advice on how to perform it.

Healio/OSN’s top blog posts of the year featured commentaries on the challenges of transitioning to office-based surgery and generic drugs for the treatment of dry eye disease.

The final 2022 issue for the Video Journal of Cataract, Refractive, and Glaucoma Surgery, which focuses on training and educating ophthalmic surgeons through video-based lessons, is now online.

High polygenic risk score in individuals with early or suspected glaucoma was associated with a faster rate of peripapillary retinal nerve fiber layer thinning and visual field worsening, a study found.

In a study using two different methods of analysis, the preclinical detectable phase for open-angle glaucoma was estimated to be approximately 10 years, suggesting that a reasonable screening interval could be 5 years.

Faster macular thinning, detected by OCT, was associated with faster subsequent rates of central visual field loss in a study.

The FDA approved Iyuzeh for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension, according to a press release from Thea Pharma.